ARCHIVES

ASCO: Anastrozole Adds Treatment Option, But Tamoxifen Remains Standard

This article is from The Cancer Letter archive.

Vol. 28 No. 33 | September 13, 2002

Download PDF Visit The Full Archive

Related Articles

Budget Manipulations “Wreaking Havoc,” Korn Tells NCAB; Legal Actions Being Considered

February 13, 1987

Cancer Letter Adds Associate Editor

July 19, 1985

News Analysis: The Political Economy of Importation to Alleviate Cancer Drug Shortages

March 2, 2012

In Brief: McIntyre New AACI President, Salmon President Elect; Hubbard NCI AD; Underleider CIB Chief

September 30, 1988

SWOG Plans Increase in Payments to Centers for Trial Accrual.

May 25, 2007

Chest X-Ray Produces Many False-Positive Results

January 27, 2006